97 related articles for article (PubMed ID: 6169548)
1. Hepatocyte targeting of adenine-9-beta-D-arabinofuranoside 5' -monophosphate (ara-AMP) coupled to lactosaminated albumin.
Fiume L; Busi C; Mattioli A; Balboni PG; Barbanti-Brodano G
FEBS Lett; 1981 Jul; 129(2):261-4. PubMed ID: 6169548
[No Abstract] [Full Text] [Related]
2. Selective penetration and pharmacological activity of lactosaminated albumin conjugates of adenine arabinoside 5-monophosphate (ara-AMP) in mouse liver.
Fiume L; Mattioli A; Busi C; Accorsi C
Gut; 1984 Dec; 25(12):1392-8. PubMed ID: 6210232
[TBL] [Abstract][Full Text] [Related]
3. A study on the pharmacokinetics in mouse of adenine-9-beta-D-arabinofuranoside 5-monophosphate conjugated with lactosaminated albumin.
Fiume L; Bassi B; Busi C; Mattioli A; Wieland T
Experientia; 1985 Oct; 41(10):1326-8. PubMed ID: 2412878
[TBL] [Abstract][Full Text] [Related]
4. Distribution of a conjugate of 9-beta-D-arabinofuranosyladenine 5'-monophosphate (ara-AMP) with lactosaminated albumin in parenchymal and sinusoidal cells of rat liver.
Fiume L; Mattioli A; Spinosa G
Cancer Drug Deliv; 1987; 4(1):11-6. PubMed ID: 2440549
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of Ectromelia virus DNA synthesis in hepatocytes by adenine-9-beta-D-arabinofuranoside (ara-A) and adenine-9-beta-D-arabinofuranoside 5'-monophosphate (ara-AMP) conjugated to asialofetuin.
Fiume L; Mattioli A; Busi C; Balboni PG; Barbanti-Brodano G; De Vries J; Altmann R; Wieland T
FEBS Lett; 1980 Jul; 116(2):185-8. PubMed ID: 6157565
[No Abstract] [Full Text] [Related]
6. 9-beta-D-arabinofuranosyl-adenine 5' monophosphate coupled to lactosaminated albumin is not metabolized in mouse bloodstream.
Fiume L; Balboni PG; Bassi B; Busi C; Mattioli A; Spinosa G
Pharm Acta Helv; 1986; 61(12):342-4. PubMed ID: 2433700
[No Abstract] [Full Text] [Related]
7. Drug targeting in antiviral chemotherapy. A chemically stable conjugate of 9-beta-D-arabinofuranosyl-adenine 5'-monophosphate with lactosaminated albumin accomplishes a selective delivery of the drug to liver cells.
Fiume L; Bassi B; Busi C; Mattioli A; Spinosa G
Biochem Pharmacol; 1986 Mar; 35(6):967-72. PubMed ID: 2420334
[TBL] [Abstract][Full Text] [Related]
8. Liver targeting of adenine arabinoside monophosphate (ara-AMP) by coupling to lactosaminated human serum albumin.
Fiume L; Busi C; Di Stefano G; Mattioli A; Torrani-Cerenzia M; Bonino F; Capra G; De Bernardi W; Ponzetto A; Lavezzo B
Ital J Gastroenterol; 1995 May; 27(4):189-92. PubMed ID: 8520036
[TBL] [Abstract][Full Text] [Related]
9. Conjugates of adenine 9-alpha-D-arabinofuranoside monophosphate (ara-AMP) with lactosaminated homologous albumin are not immunogenic in the mouse.
Fiume L; Mattioli A; Busi C; Spinosa G; Wieland T
Experientia; 1982 Sep; 38(9):1087-9. PubMed ID: 6182024
[No Abstract] [Full Text] [Related]
10. Lactosaminated human serum albumin as hepatotropic drug carrier. Rate of uptake by mouse liver.
Fiume L; Busi C; Mattioli A
FEBS Lett; 1982 Sep; 146(1):42-6. PubMed ID: 7140975
[No Abstract] [Full Text] [Related]
11. Galactosylated poly(L-lysine) as a hepatotropic carrier of 9-beta-D-arabinofuranosyladenine 5'-monophosphate.
Fiume L; Bassi B; Busi C; Mattioli A; Spinosa G; Faulstich H
FEBS Lett; 1986 Jul; 203(2):203-6. PubMed ID: 2426140
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of woodchuck hepatitis virus replication by adenine arabinoside monophosphate coupled to lactosaminated poly-L-lysine and administered by intramuscular route.
Fiume L; Di Stefano G; Busi C; Mattioli A; Rapicetta M; Giuseppetti R; Ciccaglione AR; Argentini C
Hepatology; 1995 Oct; 22(4 Pt 1):1072-7. PubMed ID: 7557853
[TBL] [Abstract][Full Text] [Related]
13. Conjugates of ara-AMP with lactosaminated albumin: a study on their immunogenicity in mouse and rat.
Fiume L; Busi C; Preti P; Spinosa G
Cancer Drug Deliv; 1987; 4(3):145-50. PubMed ID: 2453263
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin.
Fiume L; Cerenzia MR; Bonino F; Busi C; Mattioli A; Brunetto MR; Chiaberge E; Verme G
Lancet; 1988 Jul; 2(8601):13-5. PubMed ID: 2455204
[TBL] [Abstract][Full Text] [Related]
15. A conjugate of lactosaminated poly-L-lysine with adenine arabinoside monophosphate, administered to mice by intramuscular route, accomplishes a selective delivery of the drug to the liver.
Fiume L; Di Stefano G; Busi C; Mattioli A
Biochem Pharmacol; 1994 Feb; 47(4):643-50. PubMed ID: 7510478
[TBL] [Abstract][Full Text] [Related]
16. Conjugates of 9-beta-D-arabinofuranosyladenine 5'-monophosphate (ara-AMP) with lactosaminated albumin. Characterization of the drug-carrier bonds.
Fiume L; Bassi B; Bongini A
Pharm Acta Helv; 1988; 63(4-5):137-9. PubMed ID: 2464835
[No Abstract] [Full Text] [Related]
17. Adenine arabinoside monophosphate coupled to lactosaminated human albumin administered for 4 weeks in patients with chronic type B hepatitis decreased viremia without producing significant side effects.
Torrani Cerenzia M; Fiume L; De Bernardi Venon W; Lavezzo B; Brunetto MR; Ponzetto A; Di Stefano G; Busi C; Mattioli A; Gervasi GB; Bonino F; Verme G
Hepatology; 1996 Apr; 23(4):657-61. PubMed ID: 8666314
[TBL] [Abstract][Full Text] [Related]
18. A labeled 9-beta-D-arabinofuranosyladenine 5'-monophosphate having increased metabolic stability.
Baker DC; Haskell TH
Ann N Y Acad Sci; 1977 Mar; 284():30-3. PubMed ID: 81638
[No Abstract] [Full Text] [Related]
19. Neuronal phosphatase activities with ARA-AMP and ARA-ATP as substrates.
Spater HW; Schnitzer JA; Quintana N; Spater SH; Novikoff AB
J Histochem Cytochem; 1981 Jun; 29(6):693-702. PubMed ID: 6166665
[No Abstract] [Full Text] [Related]
20. Preparation of a lactosaminated albumin-ara-AMP conjugate which remains soluble after lyophilization.
Fiume L; Bassi B; Busi C; Mattioli A
Pharm Acta Helv; 1985; 60(11):318-20. PubMed ID: 2417261
[No Abstract] [Full Text] [Related]
[Next] [New Search]
